China’s Services Trade Surges 4.9% in First Four Months of 2026
The Chinese mainland’s services trade rose 4.9% in early 2026, driven by a 15% jump in exports and strong growth in knowledge-intensive services and biopharmaceutical IP.
Biopharmaceuticals
AstraZeneca Pledges $15B in China as UK Strengthens Science Ties
AstraZeneca announces $15 billion investment in China through 2030, bolstering UK-China science ties amid Prime Minister Starmer’s diplomatic engagement.
AstraZeneca CEO Praises China’s Growth and Supply Chain Efficiency
AstraZeneca CEO Pascal Soriot expresses strong confidence in China’s economic growth and supply chain efficiency, highlighting its strategic importance to the company’s global operations.
China set to lead next wave of biopharmaceutical innovation, says AstraZeneca CEO
Pascal Soriot, CEO of AstraZeneca, highlights China’s pivotal role in driving innovation in biopharmaceuticals at the Boao Forum 2024, noting the creation of well-paid jobs and a focus on quality productive forces.